Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium gluconate + calcium levulinate is an approved injectable calcium supplement developed by Laboratoires Sterop. Formulated as a solution for injection, each ampoule contains a combination of calcium gluconate and calcium levulinate, which serve to replenish calcium levels in the body. The drug acts as an agonist of the calcium-sensing receptor (CaSR), restoring calcium homeostasis, skeletal integrity, and bone mineralization. It is indicated for the treatment and prevention of acute symptomatic hypocalcemia and other calcium deficiency states, and can be administered via subcutaneous, intramuscular, or intravenous routes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium gluconate + calcium levulinate.